Biotechnology (11) | Business Formation (11)
Browse by Subcategory
Browse by Company
Recent Contracts
-
Form of Second Amended and Restated Limited Liability Company Agreement of Morgenesis LLC
(Orgenesis Inc., Filed With SEC on November 7, 2022)
-
Amended and Restated Limited Liability Company Agreement, by and between the registrant, TVAX Biomedical, Inc. and V2ACT Therapeutics, LLC, dated January 3, 2019
(GENELUX CORP, Filed With SEC on June 24, 2022)
-
Amended and Restated Limited Liability Company Agreement, dated March 10, 2022, by and among Oxford Biomedica Solutions LLC (f/k/a Roadrunner Solutions LLC), Homology Medicines,...
(Homology Medicines, Inc., Filed With SEC on March 23, 2022)
-
Sublicense Agreement, dated February 16, 2012, by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation, Pharmacopeia, Inc., a Delaware limited liability company,...
(Retrophin, Inc., Filed With SEC on February 24, 2022)
-
Third Amended and Restated Limited Liability Company Agreement, dated December 16, 2020, by and among Cullinan Oncology, LLC and its members
(Cullinan Oncology, LLC, Filed With SEC on December 18, 2020)
-
Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability...
(PROGENITY, INC., Filed With SEC on December 1, 2020)
-
Nominee Agreement, by and among Avero Laboratory Holdings, LLC, a Delaware limited liability company, Mattison Pathology, LLP d/b/a Avero Diagnostics, a Texas limited liability...
(PROGENITY, INC., Filed With SEC on June 18, 2020)
-
Plan of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation)
(Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
-
Certificate of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation)
(Zentalis Pharmaceuticals, LLC, Filed With SEC on May 15, 2020)
-
Tender and Support Agreement, dated as of January 10, 2020, by and among Eli Lilly and Company, Bald Eagle Acquisition Corporation, New Enterprise Associates 13, L.P. and NEA...
(Dermira, Inc., Filed With SEC on January 10, 2020)